...
首页> 外文期刊>Annals of allergy, asthma, and immunology >Effect of a mobile health, sensor-driven asthma management platform on asthma control
【24h】

Effect of a mobile health, sensor-driven asthma management platform on asthma control

机译:移动健康,传感器驱动的哮喘管理平台对哮喘控制的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract Background Asthma inflicts a significant health and economic burden in the United States. Self-management approaches to monitoring and treatment can be burdensome for patients. Objective To assess the effect of a digital health management program on asthma outcomes. Methods Residents of Louisville, Kentucky, with asthma were enrolled in a single-arm pilot study. Participants received electronic inhaler sensors that tracked the time, frequency, and location of short-acting ?agonist (SABA) use. After a 30-day baseline period during which reference medication use was recorded by the sensors, participants received access to a digital health intervention designed to enhance self-management. Changes in outcomes, including mean daily SABA use, symptom-free days, and asthma control status, were compared among the initial 30-day baseline period and all subsequent months of the intervention using mixed-model logistic regressions and ?2 tests. Results The mean number of SABA events per participant per day was 0.44 during the control period and 0.27 after the first month of the intervention, a 39% reduction. The percentage of symptom-free days was 77% during the baseline period and 86% after the first month, a 12% improvement. Improvement was observed throughout the study; each intervention month demonstrated significantly lower SABA use and higher symptom-free days than the baseline month ( P P P ? .80). Conclusion A digital health asthma management intervention demonstrated significant reductions in SABA use, increased number of symptom-free days, and improvements in asthma control. Trial Registration ClinicalTrials.gov Identifier: NCT02162576 .
机译:摘要背景哮喘造成大量健康和经济负担在美国。监测和治疗的自我管理方法可能是患者的繁重。目的评估数字健康管理计划对哮喘结果的影响。方法肯塔基州路易斯维尔的居民,哮喘患者入学。参与者接收了跟踪时间,频率和位置的电子吸入器传感器?激动剂(SABA)使用。在30天的基线期间,传感器记录了参考药物的基准期,参与者获得了对设计以增强自我管理的数字健康干预的访问。在使用混合模型逻辑回归和2个测试的初始30天基线期间和所有后续几个月的介入中,比较了结果的结果,包括平均每日SABA使用,症状天数和哮喘控制状态。结果控制期间每次参与者每天的SABA事件的平均数量为0.44,介入的第一个月后0.27%,减少了39%。在基线期间的无症状天数的百分比为77%,第一个月后86%,改善12%。在整个研究中观察到改善;每个干预月份都表现出显着降低的SABA使用和比基准月份更高的症状天数(p p p?.80)。结论一种数字健康哮喘管理干预表明SABA使用的显着减少,症状无症数量增加,以及哮喘控制的改善。试验登记ClinicalTrials.gov标识符:NCT02162576。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号